Development of Nanocarrier‐Based Oral Pegfilgrastim Formulations for Mitigating Hematopoietic Acute Radiation Syndrome is a research paper published in Advanced Functional Materials (2025). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Allergy and Infectious Diseases
Grant: 5 U19 AI067773
National Institutes of Health
Grant: 1F31CA275733
National Science Foundation
Grant: 1644869
NIH HHS
Grant: S10 OD026845
NCI NIH HHS
Grant: F31 CA275733
NCI NIH HHS
Grant: P30 CA013696
NCI NIH HHS
Grant: T32 CA285274
NIAID NIH HHS
Grant: U19 AI067773
FWCI
4.65
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals